Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Krell

Showing results (51-60 of 135) with videos related to

Pageof 14
Sort By:
Scientific Reports|February 27, 2020
Oncologist-led BRCA 'mainstreaming' in the ovarian cancer clinic: A study of 255 patients and its impact on their managementMegan Rumford, Mark Lythgoe, Iain McNeish, et al.
Expert Review of Anticancer Therapy|December 20, 2012
Is there a role for intravenous iron therapy in patients undergoing colorectal cancer resection?Barrie D Keeler, Jonathan Krell, Austin G Acheson, et al.
Archives of Surgery (Chicago, Ill. : 1960)|October 17, 2012
The "malignant truth" about the recurrence of pancreatic intraductal papillary mucinous neoplasmsAdam E Frampton, Madhava Pai, Jonathan Krell, et al.
Expert Review of Anticancer Therapy|November 27, 2012
Defining a prognostic molecular profile for ductal adenocarcinoma of the pancreas highlights known key signaling pathwaysAdam E Frampton, Jonathan Krell, Elisa Giovannetti, et al.
Expert Review of Molecular Diagnostics|December 22, 2012
Towards a clinical use of miRNAs in pancreatic cancer biopsiesAdam E Frampton, Tamara M H Gall, Leandro Castellano, et al.
Expert Review of Molecular Diagnostics|February 7, 2015
Activating mutations of GNAS and KRAS in cystic fluid can help detect intraductal papillary mucinous neoplasms of the pancreasAdam E Frampton, Justin Stebbing, Tamara M H Gall, et al.
Nature Reviews. Clinical Oncology|September 3, 2010
Rechallenging with anthracyclines and taxanes in metastatic breast cancerCarlo Palmieri, Jonathan Krell, Colin R James, et al.
Expert Review of Molecular Diagnostics|March 13, 2013
Blood-based miRNAs as noninvasive diagnostic and surrogative biomarkers in colorectal cancerTamara M H Gall, Adam E Frampton, Jonathan Krell, et al.
Annals of Surgery|March 21, 2014
miR-15b and miR-17 Are Tumor-derived Plasma MicroRNAs Dysregulated in Colorectal NeoplasiaAdam E Frampton, Jonathan Krell, Tamara M H Gall, et al.
Expert Review of Molecular Diagnostics|October 17, 2013
Is the detection of circulating tumor cells in locally advanced pancreatic cancer a useful prognostic marker?Tamara M H Gall, Adam E Frampton, Jonathan Krell, et al.
Pageof 14

Showing results (51-60 of 135) with videos related to

Sort By:
Pageof 14
Scientific Reports|February 27, 2020
Oncologist-led BRCA 'mainstreaming' in the ovarian cancer clinic: A study of 255 patients and its impact on their managementMegan Rumford, Mark Lythgoe, Iain McNeish, et al.
Expert Review of Anticancer Therapy|December 20, 2012
Is there a role for intravenous iron therapy in patients undergoing colorectal cancer resection?Barrie D Keeler, Jonathan Krell, Austin G Acheson, et al.
Archives of Surgery (Chicago, Ill. : 1960)|October 17, 2012
The "malignant truth" about the recurrence of pancreatic intraductal papillary mucinous neoplasmsAdam E Frampton, Madhava Pai, Jonathan Krell, et al.
Expert Review of Anticancer Therapy|November 27, 2012
Defining a prognostic molecular profile for ductal adenocarcinoma of the pancreas highlights known key signaling pathwaysAdam E Frampton, Jonathan Krell, Elisa Giovannetti, et al.
Expert Review of Molecular Diagnostics|December 22, 2012
Towards a clinical use of miRNAs in pancreatic cancer biopsiesAdam E Frampton, Tamara M H Gall, Leandro Castellano, et al.
Expert Review of Molecular Diagnostics|February 7, 2015
Activating mutations of GNAS and KRAS in cystic fluid can help detect intraductal papillary mucinous neoplasms of the pancreasAdam E Frampton, Justin Stebbing, Tamara M H Gall, et al.
Nature Reviews. Clinical Oncology|September 3, 2010
Rechallenging with anthracyclines and taxanes in metastatic breast cancerCarlo Palmieri, Jonathan Krell, Colin R James, et al.
Expert Review of Molecular Diagnostics|March 13, 2013
Blood-based miRNAs as noninvasive diagnostic and surrogative biomarkers in colorectal cancerTamara M H Gall, Adam E Frampton, Jonathan Krell, et al.
Annals of Surgery|March 21, 2014
miR-15b and miR-17 Are Tumor-derived Plasma MicroRNAs Dysregulated in Colorectal NeoplasiaAdam E Frampton, Jonathan Krell, Tamara M H Gall, et al.
Expert Review of Molecular Diagnostics|October 17, 2013
Is the detection of circulating tumor cells in locally advanced pancreatic cancer a useful prognostic marker?Tamara M H Gall, Adam E Frampton, Jonathan Krell, et al.
Pageof 14